Novo Nordisk
€36.79
20829
+€1.00+2.81% 11:02 Today
Statistics
Day High
38.34
Day Low
36.66
52W High
54.81
52W Low
30.25
Volume
6,425
Avg. Volume
-
Mkt Cap
162.25B
P/E Ratio
10.14
Dividend Yield
4.38%
Dividend
1.61
Upcoming
Dividends
4.38%Dividend Yield
Aug 2026
€0.50
Mar 2026
€1.06
Aug 2025
€0.50
Apr 2025
€1.06
Aug 2024
€0.47
10Y Growth
6.66%
5Y Growth
20.02%
3Y Growth
18.13%
1Y Growth
0.28%
Earnings
Feb 3Expected
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
0.58
0.68
0.77
0.87
Expected EPS
0.5798596136088
Actual EPS
N/A
Financials
33.14%Profit Margin
Profitable41.41BRevenue
13.72BNet Income
Analyst Ratings
$30.35Average Price Target
The highest estimate is 30.35.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 50%
Sell 50%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NOV.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sanofi
SNY
Mkt Cap106.24B
Lilly(Eli) &
LLY
Mkt Cap1.26T
Astrazeneca
AZN
Mkt Cap289.48B
Merck
MRK
Mkt Cap368.89B
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Pfizer
PFE
Mkt Cap173.95B
Novartis
NVS
Mkt Cap303.67B
Johnson & Johnson
JNJ
Mkt Cap657.68B
Abbott Laboratories
ABT
Mkt Cap183.77B
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
About
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Show More
CEO
Maziar Mike Doustdar
Employees
69500
Country
Denmark
ISIN
DK0062498333
WKN
000A3EU6F
Listings
0 Comments
Share your thoughts
FAQs
What is Novo Nordisk stock price today?▼
The current price of NOV.STU is €36.79 EUR — it has increased by +2.81% in the past 24 hours. Watch Novo Nordisk stock price performance more closely on the chart.
What is Novo Nordisk stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Novo Nordisk stocks are traded under the ticker NOV.STU.
Is Novo Nordisk stock price growing?▼
NOV.STU stock has risen by +8.72% compared to the previous week, the month change is a +11.83% rise, over the last year Novo Nordisk has showed a -12.44% decrease.
What is Novo Nordisk market cap?▼
Today Novo Nordisk has the market capitalization of 162.25B
When is the next Novo Nordisk earnings date?▼
Novo Nordisk is going to release the next earnings report on February 3, 2027.
What were Novo Nordisk earnings last quarter?▼
NOV.STU earnings for the last quarter are 0.78 EUR per share, whereas the estimation was 0.64 EUR resulting in a +22.22% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Novo Nordisk revenue for the last year?▼
Novo Nordisk revenue for the last year amounts to 41.41B EUR.
What is Novo Nordisk net income for the last year?▼
NOV.STU net income for the last year is 13.72B EUR.
Does Novo Nordisk pay dividends?▼
Yes, NOV.STU dividends are paid semi-annual. The last dividend per share was 0.5 . As of today, Dividend Yield (FWD)% is 4.38%.
How many employees does Novo Nordisk have?▼
As of November 4, 2026, the company has 69,500 employees.
In which sector is Novo Nordisk located?▼
Novo Nordisk operates in the Health & Wellness sector.
When did Novo Nordisk complete a stock split?▼
The last stock split for Novo Nordisk was on September 13, 2023 with a ratio of 2:1.
Where is Novo Nordisk headquartered?▼
Novo Nordisk is headquartered in Bagsvaerd, Denmark.